Advanced Enzyme Technologies Limited announced its unaudited financial results for the second quarter and half-year ended September 2026. The company reported a consolidated revenue of ₹2,145 million for Q2 FY27, a 16% increase year-over-year. Profit after tax for the quarter also saw a substantial rise of 14%. The half-yearly results show a 10% growth in revenue to ₹4,062 million.
Advanced Enzymes Reports Strong Financial Performance for Q2 FY27
Advanced Enzyme Technologies Limited (Advanced Enzymes) has announced its unaudited financial results for the second quarter and the half-year ended September 2026. The company has demonstrated robust financial performance, with significant year-over-year (Y-o-Y) growth across key metrics.
Consolidated Quarterly Highlights (Q2 FY27)
For the second quarter of FY27, Advanced Enzymes reported a consolidated revenue of ₹2,145 million, marking a substantial 16% increase compared to ₹1,845 million in Q2 FY26. EBITDA also saw a healthy increase of 20% to ₹721 million. Profit after tax (PAT) grew by 14% to ₹512 million from ₹447 million in the corresponding quarter of the previous year. Earnings Per Share (EPS) stood at ₹4.33, up 12% from ₹3.87 in Q2 FY26.
Consolidated Half-Yearly Review (H1 FY27)
On a half-yearly basis, revenue from operations on a consolidated basis increased by 10% to ₹4,062 million in H1 FY27, from ₹3,704 million in H1 FY26. Consolidated EBITDA for the first half grew by 7% to ₹1,250 million. Profit after tax for H1 FY27 was ₹897 million, an increase of 5% compared to ₹852 million in H1 FY26. EPS for the half-year was ₹7.64.
Segmental Performance
The company’s segmental revenue analysis for Q2 FY27 shows varied growth. Human Nutrition revenue grew by 6% to ₹1,285 million. Animal Nutrition saw a significant jump of 37% to ₹265 million. Bio-Processing delivered strong performance with a 43% Y-o-Y revenue growth to ₹365 million, driven by the Food business’s 48% growth. Specialized Manufacturing contributed 11% to total revenue with a 25% Y-o-Y increase to ₹231 million.
Geographical Performance
Domestic sales accounted for 52% of revenue in Q2 FY27, an increase from 48% in Q2 FY26, with sales growing by 25% to ₹1,110 million. International sales accounted for the remaining 48%, growing by 8% to ₹1,035 million. Growth in international markets was led by the Rest of the World (156% increase), Americas (4%), and Asia (ex-India) (6%), while Europe saw a de-growth of 10%.
Source: BSE
